Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-19
DOI
10.1038/s41598-019-42345-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients
- (2018) In Seok Yang et al. BMC BIOINFORMATICS
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- The Cancer Genome Atlas: Creating Lasting Value beyond Its Data
- (2018) Carolyn Hutter et al. CELL
- Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression
- (2018) Kentaro Inamura INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
- (2018) Qian Liu et al. Journal of Hematology & Oncology
- Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
- (2018) Ivana Catacchio et al. Translational Oncology
- Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
- (2018) Tinglu Li et al. Oncology Letters
- Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
- (2018) Adriana Albini et al. Frontiers in Immunology
- Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer
- (2017) Cristina Pérez-Ramírez et al. SURGICAL ONCOLOGY-OXFORD
- Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
- (2017) Binghua Li et al. Scientific Reports
- Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy
- (2016) Ting Yue et al. BMC CANCER
- IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer
- (2016) M. S. Caetano et al. CANCER RESEARCH
- Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy
- (2016) Yoshihisa Kobayashi et al. CANCER SCIENCE
- IL12RB2 Polymorphisms correlate with risk of lung adenocarcinoma
- (2016) Ignazia Prigione et al. IMMUNOBIOLOGY
- Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis
- (2016) Mitsuyo Yoshida et al. PLoS One
- Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation
- (2015) Yi Na Jiang et al. Oncotarget
- Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma
- (2015) Xin Li et al. Thoracic Cancer
- LAP TGF-Beta Subset of CD4+CD25+CD127−Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients
- (2015) Lorenzo Islas-Vazquez et al. Biomed Research International
- Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
- (2014) N Sunaga et al. BRITISH JOURNAL OF CANCER
- Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
- (2014) Lanxi Song et al. Journal of Thoracic Oncology
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-γ
- (2013) Savvas Petanidis et al. PLoS One
- Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer
- (2013) Xiaohong Tan et al. PLoS One
- Prognostic value of the immune microenvironment in lung adenocarcinoma
- (2013) Kyuichi Kadota et al. OncoImmunology
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- Interleukin-12: Clinical usage and molecular markers of cancer susceptibility
- (2012) Arseniy E. Yuzhalin et al. GROWTH FACTORS
- Clinical Impact of Immune Microenvironment in Stage I Lung Adenocarcinoma: Tumor Interleukin-12 Receptor β2 (IL-12Rβ2), IL-7R, and Stromal FoxP3/CD3 Ratio Are Independent Predictors of Recurrence
- (2012) Kei Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Immune Markers in Non–Small Cell Lung Cancer
- (2011) Kei Suzuki et al. CLINICAL CANCER RESEARCH
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
- (2010) Wenshu Chen Frontiers in Bioscience-Landmark
- IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms
- (2010) Elizabeth W. Sorensen et al. JOURNAL OF IMMUNOLOGY
- TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
- (2010) Rebecca L. Toonkel et al. Journal of Thoracic Oncology
- Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non–Small-Cell Lung Cancer
- (2009) Emer O. Hanrahan et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions
- (2009) Irma Airoldi et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started